Briacell Therapeutics Stock Forecast

Sell candidate since Oct 30, 2025 Loss -28.96%

The BriaCell Therapeutics Corp. stock price fell by -11.95% on the last day (Monday, 17th Nov 2025) from $9.17 to $8.07. It has now fallen 6 days in a row. During the last trading day the stock fluctuated 15.49% from a day low at $8.07 to a day high of $9.32. The price has fallen in 7 of the last 10 days and is down by -19.3% for this period. Volume has increased on the last day by 23 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 61 thousand shares were bought and sold for approximately $489.99 thousand.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $7.54 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 87.81% during the next 3 months and, with a 90% probability hold a price between $14.17 and $29.33 at the end of this 3-month period.

BCTX Signals & Forecast

There are few to no technical positive signals at the moment. The BriaCell Therapeutics Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $10.01 and $11.64. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, October 24, 2025, and so far it has fallen -41.48%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). BriaCell Therapeutics Corp. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for BriaCell Therapeutics Corp. stock

BriaCell Therapeutics Corp. finds support from accumulated volume at $7.72 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.25 between high and low, or 15.49%. For the last week, the stock has had daily average volatility of 8.32%.

BriaCell Therapeutics Corp. is oversold on RSI14 (20). Some stock may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BCTX) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect BriaCell Therapeutics Corp. to open at $8.49, and during the day (based on 14 day Average True Range), to move between $7.62 and $8.52, which gives a possible trading interval of +/-$0.89 (+/-11.69%) up or down from last closing price. If BriaCell Therapeutics Corp. takes out the full calculated possible swing range there will be an estimated 11.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $8.21 (1.73%) than the support at $7.72 (4.40%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is BriaCell Therapeutics Corp. stock A Buy?

The BriaCell Therapeutics Corp. stock holds several negative signals and despite the positive trend, we believe BriaCell Therapeutics Corp. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.064 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $8.49 ( 5.16%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk